Exogenous ketones have exploded in popularity, with claims ranging from better brain function to improved performance and weight loss. But what does the science actually say?
In this in-depth conversation, Dr. Bret Scher sits down with leading ketone researcher Dr. Dominic D'Agostino (@ketonutrition-dom4845) to break down the reality behind exogenous ketones—what they are, how they work, and where they may (or may not) fit into your health strategy.
They explore the key differences between:
Endogenous ketones (produced by your body through diet or fasting)
Exogenous ketones (supplements you consume)
And why that distinction matters for both metabolic and brain health.
This conversation covers:
The different types of exogenous ketones (salts, esters, those derived from MCTs)
Potential benefits for brain energy, seizures, and metabolic health
Safety considerations and why formulation matters
Why exogenous ketones are best viewed as a tool, not a replacement for a ketogenic diet
The concept of a “sweet spot” for ketone levels in different conditions
One of the biggest takeaways: context is everything. Exogenous ketones may offer the most benefit when used to support a well-formulated metabolic approach, rather than as a standalone shortcut.
Core thesis
Exogenous ketones are strongest when a metabolic deficit or brain energy bottleneck exists.
They augment ketogenic diet efficacy; the diet usually does most of the work for most uses.
A ketogenic diet changes substrate availability and metabolic physiology, while a ketone drink mainly raises circulating ketones.
High glucose, high insulin, and high ketones together create an uncommon fuel state that may create energy toxicity or reductive stress.
Ketosis routes and formulations
Ketosis can come from fasting, ketogenic diets, ketogenic fats such as MCT oil, ketone salts, ketone acids, and ketone esters.
MCT oil goes to the liver quickly and can raise endogenous ketones, but it is a saturated fat and may raise LDL in some people.
The liver makes ketones but cannot use them well because it lacks succinyl-CoA transferase, so ketones move into circulation for the brain, heart, kidneys, and muscle.
Plain beta-hydroxybutyric acid is acidic; larger unbuffered doses can transiently push acid-base status toward metabolic acidosis in healthy users.
Ketone salts buffer beta-hydroxybutyrate or acetoacetate with minerals and usually have a self-limiting mineral load.
Ketone esters bind ketones to another molecule through an ester bond; 1,3-butanediol based esters require liver conversion and have tolerability and long-term data limits.
The 1,3-butanediol load at common daily amounts makes the liver work like it does with ethanol on a per-gram basis in D'Agostino's account.
Clinical use and dosing logic
Exogenous ketones are strongest as an add-on to ketogenic diets for brain-centered conditions, not as a stand-alone method.
Epilepsy can require maintained ketones around 3 to 5 mmol/L for some pediatric cases, while other people feel worse above 2 to 3 mmol/L.
Cancer metabolism work uses lower ketone ranges around 1 to 2 mmol/L, because higher ketones are not always the target.
Subjective function and objective measures such as glucose, ketones, GKI, PHQ-9, or GAD-7 are paired with clinical goals.
Smaller doses, food, MCT oil, fat, fiber, and protein can slow absorption and make ketone administration safer.
Large fasting doses can be risky when a person is already ketotic.
Safety concerns and individual response
Large ketone ester doses can raise insulin, lower endogenous beta-oxidation, and later leave ketones and glucose low.
Ketone salts did not raise insulin in D'Agostino's experience, because mineral load limits the dose.
MCT oil is a conservative first option for raising ketones, but empty-stomach use often causes gastrointestinal problems.
DL beta-hydroxybutyrate salts are the next conservative option in D'Agostino's practical hierarchy.
D-beta-hydroxybutyrate may be more direct for energy, while L-beta-hydroxybutyrate clears more slowly and may have stronger signaling effects.
Combining MCT, DL beta-hydroxybutyrate salt, and limited acid can sustain ketones better than a single ketone molecule.
Evidence and open areas
Animal hyperbaric oxygen experiments used acute ketone administration before 5 ATA oxygen exposure and found seizure delays in the 200% to 600% range.
Human RCT data exist but are small; larger human studies are still needed for clinical uses.
A recent low-dose beta-hydroxybutyrate RCT used 2 grams and found psychomotor vigilance and possible grip-strength signals.
D and L enantiomer pharmacokinetics, brain uptake, and brain effects remain an active area.
Exogenous ketones may have a trajectory similar to creatine, with early sports use followed by broader work in cognition, mood, sleep deprivation, and aging.
D'Agostino's personal regimen and monitoring
D'Agostino now uses a low-carbohydrate Mediterranean-style diet that often sits near mild ketosis.
D'Agostino adds DL beta-hydroxybutyrate salts, often with creatine monohydrate, to raise ketones modestly.
D'Agostino uses exogenous ketones for sustained energy and appetite reduction more than weightlifting performance.
D'Agostino had years of high LDL and ApoB on ketogenic diets, later shifted toward lower-carbohydrate Mediterranean eating, and monitors blood markers closely.
D'Agostino's monitoring includes lipid markers, inflammation markers, glucose markers, omega-3 status, heavy metals, metabolomics, and vascular imaging.
Practical takeaways
The choice of ketone product depends on goal, baseline metabolic state, dose, formulation, timing, and measured response.
Brain energy conditions are the main area where ketone level targeting may matter most.
Weight loss marketing is less central than metabolic and neurological use here.
Long-term human data are limited, so clinical teamwork and lab monitoring matter when ketones are used for specific conditions.
Ketone salts and MCT-based approaches are the favored conservative starting points; 1,3-butanediol-heavy esters receive the most caution.
[00:10] An open-label, acute clinical trial in adults to assess ketone levels, gastrointestinal tolerability and sleepiness following consumption of (R)-1,3-butanediol — https://doi.org/10.3389/fphys.2023.1195702